Male lower urinary tract symptoms and α1D-adrenoceptors

International Journal of Urology

Volumn 20, Issue 1, 2013, Pages 73-78

  Ishizuka, Osamu ^a   Imamura, Tetsuya ^a   Kurizaki, Yoshiki ^a   Nishizawa, Osamu ^a   Andersson, Karl Erik ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

1 adrenoceptor subtypes; Bladder; Storage symptoms; Voiding dysfunction; Voiding symptoms

Indexed keywords

8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ACETIC ACID; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; MESSENGER RNA; NAFTOPIDIL; PRAZOSIN; TAMSULOSIN;

BLADDER CAPACITY; BLADDER CONTRACTION; BLADDER DYSFUNCTION; BLADDER MUCOSA; BLADDER NECK STENOSIS; BLADDER OBSTRUCTION; GENE EXPRESSION; HUMAN; KNOCKOUT MOUSE; LOWER URINARY TRACT SYMPTOM; MICTURITION; MICTURITION REFLEX; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVIEW; SENSORY NERVE; URINARY FREQUENCY; URINARY URGENCY; URINE VOLUME;

ANIMALS; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MICE; RECEPTORS, ADRENERGIC, ALPHA-1; URINARY BLADDER; URINARY BLADDER NECK OBSTRUCTION;

EID: 84871930645     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2012.03223.x     Document Type: Review

References (41)

1. Andersson KE, Gratzke C. Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat. Clin. Pract. Urol. 2007; 4: 368-378.
2. 1-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 7159-7163.
3. 1A-adrenergic receptor. The gene for which is located on human chromosome 5. J. Biol. Chem. 1991; 266: 6365-6369.
4. 1D-adrenergic receptor cDNA. Mol. Pharmacol. 1991; 40: 876-883.
5. 1C-adrenergic receptor: a new member in the alpha 1-adrenergic receptor family. Trans. Assoc. Am. Physicians 1990; 103: 112-118.
6. 1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. J. Pharmacol. Exp. Ther. 1995; 272: 134-142.
7. Persson K, Pandita RK, Spitsbergen JM, Steers WD, Tuttle JB, Andersson KE. Spinal and peripheral mechanisms contributing to hyperactive voiding in spontaneously hypertensive rats. Am. J. Physiol. 1998; 275: R1366-1373.
8. Chai TC, Gemalmaz H, Andersson KE, Tuttle JB, Steers WD. Persistently increased voiding frequency despite relief of bladder outlet obstruction. J. Urol. 1999; 161: 1689-1693.
9. Dmitrieva N, Zhang G, Nagabukuro H. Increased α1D adrenergic receptor activity and protein expression in the urinary bladder of aged rats. World J. Urol. 2008; 26: 649-655.
10. Barendrecht MM, Frazier EP, Vrydag W, Alewijnse AE, Peters SL, Michel MC. The effect of bladder outlet obstruction on alpha1- and beta-adrenoceptor expression and function. Neurourol. Urodyn. 2009; 28: 349-355.
11. Hampel C, Dolber PC, Smith MP etal. Modulation of bladder alpha1-adrenergic receptor subtype expression by bladder outlet obstruction. J. Urol. 2002; 167: 1513-1521.
12. Gu B, Reiter JP, Schwinn DA etal. Effects of alpha 1-adrenergic receptor subtype selective antagonists on lower urinary tract function in rats with bladder outlet obstruction. J. Urol. 2004; 172: 758-762.
13. Imamura T, Ishizuka O, Kurizaki Y etal. Distribution of α1-adrenoceptor subtype in urinary bladder of bladder outlet obstruction model in rats. NBS 2009; 20: 172.
14. Imamura T, Ishizuka O, Kurizaki Y etal. Changes in the expression of α1-adrenoceptor subtype in urinary bladder of spontaneous hypertensive rats with loading of NaCl. Jpn. J. Urol. 2011; 102: 502.
15. Chen Q, Takahashi S, Zhong S etal. Function of the lower urinary tract in mice lacking alpha1d-adrenoceptor. J. Urol. 2005; 174: 370-374.
16. 1D receptor is predominantly involved in the adrenergic facilitation of micturition reflex. LUTS 2009; 1: S10-14.
17. 1D adrenergic receptors in the rat urothelium facilitates the micturition reflex. J. Urol. 2006; 175: 358-364.
18. Sugaya K, Nishijima S, Tasaki S, Kadekawa K, Miyazato M, Ogawa Y. Effects of propiverine and naftopidil on the urinary ATP level and bladder activity after bladder stimulation in rats. Neurosci. Lett. 2007; 429: 142-146.
19. Imamura T, Ishizuka O, Aizawa N etal. Cold environmental stress induces detrusor overactivity via resiniferatoxin-sensitive nerves in conscious rats. Neurourol. Urodyn. 2008; 27: 348-352.
20. Chen Z, Ishizuka O, Imamura T etal. Stimulation of skin menthol receptors stimulates detrusor activity in conscious rats. Neurourol. Urodyn. 2010; 29: 506-511.
21. Noguchi W, Imamura T, Ishizuka O etal. Increased skin TRPM8 by estrogen deficiency may induce detrusor overactivity mediated Alpha1D-adrenergic receptors triggered by sudden cold stress. J. Urol. 2012; [Epub ahead of print].
22. Malloy BJ, Price DT, Price RR etal. α1-adrenergic receptor subtypes in human detrusor. J. Urol. 1998; 160: 937-943.
23. Rudner XL, Berkowitz DE, Booth JV etal. Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age. Circulation 1999; 100: 2336-2343.
24. Price DT, Lefkowitz RJ, Caron MG, Berkowitz D, Schwinn DA. Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology. Mol. Pharmacol. 1994; 45: 171-175.
25. Nomiya M, Yamaguchi O. A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J. Urol. 2003; 170: 649-653.
26. Chapple CR, Smith D. The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia. Br. J. Urol. 1994; 73: 117-123.
27. Bouchelouche K, Andersen L, Alvarez S, Nordling J, Bouchelouche P. Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and α1D-adrenergic receptor antagonist tamsulosin. J. Urol. 2005; 173: 657-661.
28. Kurizaki Y, Ishizuka O, Imamura T etal. Relation between expression of α(1)-adrenoceptor mRNAs in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms. Scand. J. Urol. Nephrol. 2011; 45: 15-19.
29. D'Agostino G, Bolognesi ML, Lucchelli A etal. Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype. Br. J. Pharmacol. 2000; 129: 493-500.
30. 3-adrenoceptors in urinary bladder. Neurourol. Urodyn. 2007; 26: 752-756.
31. Okada S, Kojima Y, Hamamoto S, Mizuno K, Sasaki S, Kohri K. Dietary soy isoflavone replacement improves detrusor overactivity of ovariectomized rats with altered connexin-43 expression in the urinary bladder. BJU Int. 2009; 103: 1429-1435.
32. Azadzoi KM, Radisavljevic ZM, Golabek T, Yalla SV, Siroky MB. Oxidative modification of mitochondrial integrity and nerve fiber density in the ischemic overactive bladder. J. Urol. 2010; 183: 362-369.
33. Paick JS, Ku JH, Shin JW, Yang JH, Kim SW. -blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: a prospective study of response prediction. BJU Int. 2006; 97: 1017-1023.
34. Yoshida M, Inadome A, Masunaga K, Nagata T, Yoshiyasu T. Effectiveness of tamsulosin hydrochloride and its mechanism in improving nocturia associated with lower urinary tract symptoms/benign prostatic hyperplasia. Neurourol. Urodyn. 2010; 29: 1276-1281.
35. Yokoyama O, Aoki Y, Tsujimura A, Takao T, Namiki M, Okuyama A. α(1)-adrenoceptor blocker naftopidil improves sleep disturbance with reduction in nocturnal urine volume. World J. Urol. 2011; 29: 233-238.
36. Watanabe M, Yamanishi T, Mizuno T etal. Effects of silodosin on lower urinary tract symptoms in patients with benign prostatic hyperplasia: evaluation by frequency/volume chart. LUTS. 2010; 2: 31-36.
37. Nishino Y, Masue T, Miwa K, Takahashi Y, Ishihara S, Deguchi T. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study. BJU Int. 2006; 97: 747-751.
38. Kakizaki H, Tanaka H, Mitsui T, Nonomura K. Clinical efficacy of α1-blocker naftopidil in patients with overactive bladder associated with benign prostatic hyperplasia. LUTS 2009; 1: 35-39.
39. 1 adrenergic receptor subtypes in human prostate. J. Urol. 1993; 150: 546-551.
40. 1-adrenoceptor subtypes by real-time RT-PCR and correlation with age and prostate volume in benign prostatic hyperplasia patients. Prostate 2006; 66: 761-767.
41. 1-adrenoceptor antagonists in the management of benign prostatic hyperplasia. J. Urol. 2008; 179: 1040-1046.